Literature DB >> 3109089

Valproate for epilepsy in renal transplant recipients receiving cyclosporine.

G Hillebrand, L A Castro, W van Scheidt, D Beukelmann, W Land, D Schmidt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3109089

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  8 in total

1.  Seizure treatment in transplant patients.

Authors:  Paul W Shepard; Erik K St Louis
Journal:  Curr Treat Options Neurol       Date:  2012-08       Impact factor: 3.598

Review 2.  Pharmacokinetic drug interactions with cyclosporin (Part II).

Authors:  G C Yee; T R McGuire
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

Review 3.  Clinically significant drug interactions with cyclosporin. An update.

Authors:  C Campana; M B Regazzi; I Buggia; M Molinaro
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

Review 4.  Pharmacokinetics of haloperidol: an update.

Authors:  S Kudo; T Ishizaki
Journal:  Clin Pharmacokinet       Date:  1999-12       Impact factor: 6.447

Review 5.  Clinically significant pharmacokinetic drug interactions with carbamazepine. An update.

Authors:  E Spina; F Pisani; E Perucca
Journal:  Clin Pharmacokinet       Date:  1996-09       Impact factor: 6.447

6.  What is the appropriate management, including drug therapy, for epilepsy in a child with a renal transplant?

Authors:  R O Robinson
Journal:  Pediatr Nephrol       Date:  1993-08       Impact factor: 3.714

7.  Effects of valproic acid coadministration on plasma efavirenz and lopinavir concentrations in human immunodeficiency virus-infected adults.

Authors:  Robert DiCenzo; Derick Peterson; Kim Cruttenden; Gene Morse; Garret Riggs; Harris Gelbard; Giovanni Schifitto
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

Review 8.  Therapeutic drug monitoring of cyclosporin. Practical applications and limitations.

Authors:  V Rodighiero
Journal:  Clin Pharmacokinet       Date:  1989-01       Impact factor: 6.447
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.